4725-83-1 Usage
Uses
Used in Pharmaceutical Industry:
1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-methylis used as an intermediate in the synthesis of various pharmaceuticals and active pharmaceutical ingredients (APIs) for its ability to contribute to the development of new medications.
Used in Cancer Treatment Research:
1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-methylis being studied for its potential use in the treatment of various types of cancer due to its chemical structure and properties that may interact with biological targets relevant to cancer progression.
Used in Neurological Disease Treatment Research:
1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-methylis also being investigated for its possible application in the treatment of neurological diseases, given its potential to interact with specific biological pathways involved in these conditions.
Used in Organic Electronic Materials:
1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-methylhas been explored for its potential application in the field of organic electronics, where its unique properties may contribute to the development of new materials for electronic devices.
Used in Industrial Processes:
1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-methylmay also find use in various industrial processes, where its chemical properties could be harnessed for specific applications or to improve existing processes.
Check Digit Verification of cas no
The CAS Registry Mumber 4725-83-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,2 and 5 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 4725-83:
(6*4)+(5*7)+(4*2)+(3*5)+(2*8)+(1*3)=101
101 % 10 = 1
So 4725-83-1 is a valid CAS Registry Number.
4725-83-1Relevant academic research and scientific papers
Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
-
, (2008/06/13)
Aryl-fused- and hetaryl-fused-2,4-diazepines of formula XXXVI, benzodiazocines of formula XXX, benzodiazepines of formula II STR1 δ-aminoamides of formula III and aryldimethanamines of formula XXXVII STR2 wherein A is an aryl or hetaryl ring; R1 is hydrogen, alkyl, aryl or hetaryl; R2 is hydrogen, alkyl, substituted alkyl, or aryl; R3 is alkyl, aryl, aralkyl or heteroatom substituted alkyl or aralkyl; R4 is hydrogen or alkyl; R5 is hydrogen, alkyl, aryl or hetaryl; R6 is hydrogen, alkyl, alkoxy, halogen or a fused benzene ring; R9 is hydrogen, alkyl, or substituted alkyl; and R10 is hydrogen, alkyl, or substituted alkyl. The invention further relates to processes for the preparation of, pharmaceutical compositions containing, and methods of treating cardiac arrhythmia with the compounds of formulas XXXVI, XXX, II, III, and XXXVII.
